Outcome of screening by clinical examination of the breast in a trial in the Philippines

International Journal of Cancer

Volumn 118, Issue 1, 2006, Pages 149-154

  Pisani, Paola ^a   Parkin, D M ^a   Ngelangel, Corazon ^b   Esteban, Divina ^c   Gibson, Lorna ^a,d   Munson, Marilou ^e   Reyes, Mary Grace ^f   Laudico, Adriano ^g  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c UP Manila College of Nursing   (Philippines)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e DEPARTMENT OF HEALTH   (Philippines)

^f National Capital Regional Health Office   (Philippines)

^g Manila Cancer Registry   (Philippines)

Author keywords

Breast clinical examination; Female breast cancer; Mass screening; Philippines

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST EXAMINATION; BREAST TUMOR; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PHILIPPINES; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; MIDWIFERY; NEOPLASM STAGING; NURSES; PHILIPPINES; PHYSICAL EXAMINATION; SENSITIVITY AND SPECIFICITY;

EID: 27944509149     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21343     Document Type: Article

References (38)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl):S4-66.
2. EBCTCG-Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998a;351:1451-67.
3. EBCTCG-Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998b;352:930-42.
4. Beral V, Hermon C, Reeves G, Peto R. Sudden fall in breast cancer death rates in England and Wales. Lancet 1995;345:1642-3.
5. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6:229-39.
6. Tyczynski JE, Plesko I, Aareleid T, Primic-Zakelj M, Dalmas M, Kurtinaitis J, Stengrevics A, Parkin DM. Breast cancer mortality patterns and time trends in 10 European countries (new EU member states): mortality declining in young women, but still increasing in the elderly. Int J Cancer 2004;112:1056-64.
7. Olivotto IA, Bajdik CD, Plenderleith IH, Coppin CM, Gelmon KA, Jackson SM, Ragaz J, Wilson KS, Worth A. Adjuvant systemic therapy and survival after breast cancer. N Engl J Med 1994;330:805-10.
8. Sankaranarayanan R, Black R, Parkin DM. Cancer survival in developing countries, IARC Scientific Publications No 145. Lyon: IARC Press, 1998. 173 p.
9. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer incidence in five continents, Vol. VIII, IARC Scientific Publications No 155. Lyon: IARC, 2002, 782 p.
10. Mammatech Corporation, Gainesville, Florida, USA. 〈www. mammacare.com〉 2003.
11. Fletcher SW, O'Malley MS, Earp JL, Morgan TM, Lin S, Degnan D. How best to teach women breast self-examination. A randomized controlled trial. Ann Intern Med 1990;112:772-9.
12. Hall DC, Adams CK, Stein GH, Stephenson HS, Goldstein MK, Pennypacker HS. Improved detection of human breast lesions following experimental training. Cancer 1980;46:408-14.
13. Pilgrim C, Lannon C, Harris RP, Cogburn W, Fletcher SW. Improving clinical breast examination training in a medical school: a randomised controlled trial. J Gen Intern Med 1993;8:685-8.
14. Campbell HS, Fletcher SW, Pilgrim CA, Morgan TM, Lin S. Improving physicians' and nurses' clinical breast examination: a randomized controlled trial. Am J Prev Med 1991;7:1-8.
15. Yeole BB, Jayant K, Jussawalla DJ. Trends in breast cancer incidence in greater Bombay: an epidemiological assessment. Bull World Health Org 1990;68:245-9.
16. Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF Jr, Gao YT. Cancer incidence trends in urban Shanghai, 1972-1994: an update. Int J Cancer 1999;83:435-40.
17. Seow A, Duffy SW, McGee MA, Lee J, Lee HP. Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol 1996;25:40-5.
18. Leung GM, Thach TQ, Lam TH, Hedley AJ, Foo W, Fielding R, Yip PS, Lau EM, Wong CM. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer 2002;87:982-8.
19. IARC. IARC breast cancer screening. Handbook of cancer prevention 2002. vol. 7. Lyon: IARC, 2002.
20. Anderson BO Global summit consensus conference on international breast health care: Guidelines for countries with limited resources. Breast J 2003;9(Suppl):S40-1.
21. WHO. National cancer control programmes. Geneva: WHO, 2002.
22. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, Pan LD, Li W, Wu C, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002;94:1445-57.
23. Baines CJ, Miller AB. Mammography versus clinical examination of the breasts. Natl Cancer Inst Monogr 1997;22:125-9.
24. Miller AB, Baines CJ, Wall C. Canadian National Breast Screening Study-2. 13-year results of a randomized trial in women aged 50-59. J Natl Cancer Inst 2000;92:1490-9.
25. Kuroishi T, Hirose K, Suzuki T, Tominaga S. Effectiveness of mass screening for breast cancer in Japan. Breast Cancer 2000;7:1-8.
26. Kanemura S, Tsuji I, Ohuchi N, Takei H, Yokoe T, Koibuchi Y, Ohnuki K, Fukao A, Satomi S, Hisamichi S. A case-control study on the effectiveness of breast cancer screening by clinical breast examination in Japan. Jpn J Cancer Res 1999;90:607-13.
27. Mitra N, Schnabel FR, Neugut AI, Heitjan DF. Estimating the effect of an intensive surveillance program on stage of breast carcinoma at diagnosis: a propensity score analysis. Cancer 2001;91:1709-15.
28. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA 2004;291:71-8.
29. Ellman R, Angeli N, Christians A, Moss S, Chamberlain J, Maguire P. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 1989;60:781-4.
30. Gram IT, Slenker SE. Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited. Am J Public Health 1992;82:249-51.
31. Sutton S, Saidi G, Bickler G, Hunter J. Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. J Epidemiol Community Health 1995;49:413-8.
32. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657-61.
33. Cockburn J, Staples M, Hurley SF, De Luise T. Psychological consequences of screening mammography. J Med Screen 1994;1:7-12.
34. Olsson P, Armelius K, Nordahl G, Lenner P, Westman G. Women with false positive screening mammograms: how do they cope? J Med Screen 1999;6:89-93.
35. Redelmeier DA, Rozin P, Kahneman D. Understanding patients' decisions. Cognitive and emotional perspectives. JAMA 1993;270:72-6.
36. Braun S. The history of breast cancer advocacy. Breast J 2003;9(Suppl):S101-3.
37. Barton MB, Harris R, Fletcher SW. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? J Am Med Assoc 1999;282:1270-80.
38. Baines CJ, Miller AB, Bassett AA. Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study. Cancer 1989;63:1816-22.